Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 2 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Honshu Chemical Industry Co. Ltd. is currently managing 6 pending office actions in the Biotechnology & Pharmaceuticals technology area. These 6 pending office actions are distributed across 5 distinct examiners and 2 distinct art units. WARD, PAUL V is the busiest examiner, currently overseeing 2 of the pending actions.
The concentration of those matters under WARD, PAUL V gives this examiner a significant influence over the portfolio's immediate trajectory. However, the use of 5 distinct examiners for the matters still provides a good degree of decentralization. The involvement of only those art units indicates that the company's innovations are focused on specific technical areas within Biotechnology & Pharmaceuticals.
Practitioners should monitor the matters under WARD, PAUL V for potential trends in examiner feedback. The examiners will likely provide a variety of perspectives, even within the units. This structure requires a strategy that is both focused on the busiest examiner's requirements and flexible enough to address the feedback from the other examiners across the 6 pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §102 only | 1 (17%) |
| §112 only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WARD, PAUL V | 2 | 83.2% | -12.2% |
| BERRO, ADAM JOSEPH | 1 | 51.8% | +45.2% |
| FROST, ANTHONY J | 1 | 52.7% | +20.1% |
| WASHVILLE, JEFFREY D | 1 | 80.0% | -4.5% |
| KELLY-O'NEILL, YOLANDA LYNNETTE | 1 | 33.3% | +29.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18262151 | METHOD FOR PRODUCING BENZOXAZINE COMPOUND | WARD, PAUL V | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18580119 | CURABLE RESIN COMPOSITION, VARNISH, PREPREG, AND CURED PRODUCT | WASHVILLE, JEFFREY D | — |
| 18262136 | NOVEL METHOD FOR PRODUCING BENZOXAZINE COMPOUND | WARD, PAUL V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17771427 | METHOD FOR PRODUCING 2,2'-BIS(CARBOXYMETHOXY)-1,1'-BINAPHTHYL | KELLY-O'NEILL, YOLANDA LYNNETTE | 34d |
| 18683485 | POLYIMIDE, POLYIMIDE VARNISH, AND POLYIMIDE THIN FILM | BERRO, ADAM JOSEPH | — |
| 18293134 | NOVEL BENZOXAZINE COMPOUND, RESIN RAW MATERIAL COMPOSITION CONTAINING THE SAME, CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | FROST, ANTHONY J | — |
| Art Unit | Apps |
|---|---|
| 1622 | 2 |
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18683485 | POLYIMIDE, POLYIMIDE VARNISH, AND POLYIMIDE THIN FILM | BERRO, ADAM JOSEPH | — | §112 | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18293134 | NOVEL BENZOXAZINE COMPOUND, RESIN RAW MATERIAL COMPOSITION CONTAINING THE SAME, CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | FROST, ANTHONY J | — | §103 | Non-Final OA | — | Pending | Jan 29, 2024 |
| 18580119 | CURABLE RESIN COMPOSITION, VARNISH, PREPREG, AND CURED PRODUCT | WASHVILLE, JEFFREY D | — | §102§103 | Non-Final OA | — | Pending | Jan 17, 2024 |
| 18262136 | NOVEL METHOD FOR PRODUCING BENZOXAZINE COMPOUND | WARD, PAUL V | 1622 | §102§103 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18262151 | METHOD FOR PRODUCING BENZOXAZINE COMPOUND | WARD, PAUL V | 1622 | §102 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 17771427 | METHOD FOR PRODUCING 2,2'-BIS(CARBOXYMETHOXY)-1,1'-BINAPHTHYL | KELLY-O'NEILL, YOLANDA LYNNETTE | 1692 | §103 | Final Rejection | 34d | Pending | Apr 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial